U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C8H19N.H3O4P
Molecular Weight 227.2383
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OCTODRINE PHOSPHATE

SMILES

OP(O)(O)=O.CC(C)CCCC(C)N

InChI

InChIKey=UGKNTPUWARSSNM-UHFFFAOYSA-N
InChI=1S/C8H19N.H3O4P/c1-7(2)5-4-6-8(3)9;1-5(2,3)4/h7-8H,4-6,9H2,1-3H3;(H3,1,2,3,4)

HIDE SMILES / InChI

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/6891293 | https://www.ncbi.nlm.nih.gov/pubmed/14881080

Octodrine is a stimulant that is structurally similar to amphetamine and is included in several so-called “pre-workout” and “fat-burning” supplements. Octodrine, has a history of use as a pharmaceutical drug. It was originally developed in the United States as an aerosolized treatment for bronchitis, laryngitis and other conditions Initially approved by the FDA in 1946 as Eskay’s Oralator, this inhaler appeared only in the 1949 edition of the Physicians’ Desk Reference. Octodrine was combined with several other medications, including theophylline, 3-octopamine, and adenosine, in multi-ingredient tablets sold between the early 1960s through the mid-2000s under the trade names Ambredin, Ordinal, Ordinal Retard and Ordinal Forte. Some proponents say octodrine is a safer alternative to other stimulants like ephedra and Dimethylamylamine (DMAA), but there is no scientific information to support this claim. Originally developed in the early 1950’s as a remedy to nasal congestion and as a possible anti-tumor drug, Octodrine has resurfaced as a key ingredient in dietary supplements for its stimulant and thermogenic benefits.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Separation and conductimetric detection of C1-C7 aliphatic monocarboxylic acids and C1-C7 aliphatic monoamines on unfunctionized polymethacrylate resin columns.
2004 Jun 11
On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors.
2009 Nov 1
Patents

Patents

Sample Use Guides

Maximum daily intake 8.5 g
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
OCTODRINE PHOSPHATE
WHO-DD  
Common Name English
Octodrine phosphate [WHO-DD]
Common Name English
2-HEPTANAMINE, 6-METHYL, PHOSPHATE
Common Name English
Code System Code Type Description
PUBCHEM
139033069
Created by admin on Sat Dec 16 04:54:25 GMT 2023 , Edited by admin on Sat Dec 16 04:54:25 GMT 2023
PRIMARY
FDA UNII
I254D74U8J
Created by admin on Sat Dec 16 04:54:25 GMT 2023 , Edited by admin on Sat Dec 16 04:54:25 GMT 2023
PRIMARY